Data for: Predictors of severe symptomatic laboratory-confirmed SARS-COV-2 reinfection

Published: 12 February 2021| Version 1 | DOI: 10.17632/phh6dsc778.1
Efrén Murillo-Zamora,
Oliver Mendoza-Cano,
Iván Delgado-Enciso,
Carlos Moisés Hernández Suárez


In the manuscript, we analyzed disease outcomes in a large set (n = 258) of adults with laboratory-confirmed symptomatic SARS-COV-2 reinfection. The implications of reinfection are highly relevant for health policymakers and our results may be useful to achieve a better understanding of the pathogenic mechanism of COVID-19.